Who qualifies

Mesh harm and a claim: what needs review

Mesh use alone does not decide a claim. A lawyer needs the product, harm and legal dates.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202614 sources

This may apply to you if

  • Prepare the mesh name, reason for repair and route used.
  • List symptoms, later care and the dates you know.
  • Bring any old claim or deal papers; ask a lawyer about your route.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

U.S. Food and Drug Administration · Publisher of the dated POP mesh review and stop-sale record

Finding: In its October 2022 POP review entry, FDA kept an unfavorable benefit-risk assessment for vaginal prolapse mesh because of added exposure and erosion risks. That assessment is distinct from its sling review and from a diagnosis in any one patient.

FDA: dated POP and sling review activities (opens in a new tab) · Oct 17, 2022 · Checked Oct 3, 2026

The evidence and its limits

United States Food and Drug Administration · 2022

FDA 2021/2022 final reviews of transvaginal prolapse mesh follow-up

Design:
Agency review
Participants:
Agency reviews of separate manufacturer studies; no combined participant total supplied on this page
Finding:
Similar outcomes to own-tissue repair at 36 months, but added exposure/erosion risks led FDA to maintain an unfavorable benefit-risk finding for vaginal POP mesh.
Main limitation
Specific POP devices and 36-month follow-up; not bladder slings or abdominal repair. No individual harm rate; underlying full reports not independently read.

Read the source: FDA 2021/2022 final reviews of transvaginal prolapse mesh follow-up (opens in a new tab) · Checked Oct 3, 2026

The short answer

Who may qualify for a mesh injury claim?
Ask a lawyer about the actual product and harm. A public warning is not a personal claim decision. The records and law need review. [7]
What does not qualify as proof by itself?
Prior mesh use alone does not prove harm or fault. A symptom list is not your diagnosis. A later operation does not guarantee a payment. [4]
What if my case is unusual or involves more than one device?
Describe each procedure as a separate event. Do not assume all mesh served the same purpose. Ask which product the claimed harm concerns. [2]
What records help with the injury review?
Keep the surgery and follow-up notes. Add reports of the problem and later care. Ask for the device name and available product papers. [12]

What rules a case out

Not covered by this case

  • A general finding does not decide the cause of your own harm.
  • These dated records do not decide a personal claim or care plan.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

The criteria attorneys check

  1. 01

    Prepare the mesh name, reason for repair and route used.

  2. 02

    List symptoms, later care and the dates you know.

  3. 03

    Bring any old claim or deal papers; ask a lawyer about your route.

Mesh use alone does not decide a claim. A lawyer needs the product, harm and legal dates. Keep confirmed findings separate from symptoms still under review.

Who may qualify for a mesh injury claim?

Ask a lawyer about the actual product and harm. A public warning is not a personal claim decision. The records and law need review.

Identify whether mesh treated prolapse or urine leakage and how it was placed. FDA reviews those uses separately. The historical court order also distinguishes general product evidence from evidence about one person’s cause; it does not supply a current firm acceptance checklist.

What does not qualify as proof by itself?

Prior mesh use alone does not prove harm or fault. A symptom list is not your diagnosis. A later operation does not guarantee a payment.

FDA lists possible complications and explains the limits of adverse-event reports. Some listed problems can also occur after repair without mesh. Tell the reviewer if a concern is under investigation or if a clinician identified a different explanation.

What if my case is unusual or involves more than one device?

Describe each procedure as a separate event. Do not assume all mesh served the same purpose. Ask which product the claimed harm concerns.

A prolapse operation may include a procedure for urine leakage. A sling and abdominal prolapse mesh differ from vaginal POP mesh covered by the 2019 stop-sale action. If the product or route is unknown, request the chart instead of filling the gap with a brand name.

What records help with the injury review?

Keep the surgery and follow-up notes. Add reports of the problem and later care. Ask for the device name and available product papers.

Keep symptom descriptions alongside examination findings rather than replacing one with the other. Ask the provider about patient access and possible copying charges. A missing label is a missing fact to investigate, not a reason to invent a device identity.

Is there a deadline for a mesh injury claim?

The law and type of claim control time to file. There is no personal date supplied by these records. Ask a lawyer to check your history promptly.

Bring earlier symptoms, implant and later procedure dates, locations and any filed-case papers. The 2019 Wave 12 dates apply to specified cases then in court. Do not assume a revision operation, FDA warning or MDL closure restarted your time.

What happens when I check a possible injury claim?

Ask what facts have been confirmed and what is missing. Clarify whether any legal action has been taken. Read the fee and expense terms before agreeing.

A federal civil case begins with a filed complaint; sending an inquiry is a different step. The ABA model rule calls for written contingent-fee terms covering percentages and expenses. Neither source establishes the handling firm’s current acceptance, price or promise to preserve your date.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. FDA mesh activities: POP stop-sale and later reviewsFDA mesh activities: POP stop-sale and later reviews · regulator
  2. FDA patient information: pelvic organ prolapseFDA patient information: pelvic organ prolapse · regulator
  3. FDA patient information: stress urinary incontinenceFDA patient information: stress urinary incontinence · regulator
  4. FDA guidance: vaginal versus abdominal prolapse meshFDA guidance: vaginal versus abdominal prolapse mesh · regulator
  5. FDA review: mini-slings for stress urinary incontinenceFDA review: mini-slings for stress urinary incontinence · regulator
  6. PROSPECT original four- and six-year randomized follow-upPROSPECT original four- and six-year randomized follow-up · study
  7. Ethicon MDL2327 Pretrial Order337, entered May1,2019Ethicon MDL2327 Pretrial Order337, entered May1,2019 · court
  8. Southern District of West Virginia: Ethicon MDL2327 public archiveSouthern District of West Virginia: Ethicon MDL2327 public archive · court
  9. JPML cumulative terminated litigations through September30,2025JPML cumulative terminated litigations through September30,2025 · court
  10. New Jersey courts: Pelvic Mesh/Gynecare dated orders indexNew Jersey courts: Pelvic Mesh/Gynecare dated orders index · court
  11. ABA Model Rule1.5: feesABA Model Rule1.5: fees
  12. HHS individual access to health informationHHS individual access to health information · regulator
  13. SDNY: how long to file a complaintSDNY: how long to file a complaint · court
  14. US Courts: civil casesUS Courts: civil cases · court

Checked against 14 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026